Recombinant Human AK3L1 Protein，GST

AK3L1, or Adenylate Kinase 3-Like 1, is a member of the adenylate kinase family, playing a critical role in cellular energy homeostasis by catalyzing the conversion of ADP to ATP and AMP. This enzyme is essential in maintaining the balance of adenine nucleotides, which is crucial for numerous cellular functions, including metabolism, signal transduction, and cellular stress responses. Research into AK3L1 is gaining momentum due to its potential implications in various diseases, including cancer and metabolic disorders. Altered expression or activity of AK3L1 has been associated with abnormal cell proliferation and survival, prompting investigations into its role as a therapeutic target. Furthermore, the recombinant expression of AK3L1 facilitates a deeper understanding of its biochemical properties and interactions with other cellular components, making it a valuable tool for elucidating its function in physiological and pathological contexts. Recent studies have also explored the protein's role in mitochondrial dynamics and its influence on apoptosis, highlighting its significance in both energy metabolism and cell fate regulation. Understanding AK3L1's mechanisms and pathways could pave the way for novel interventions in diseases characterized by cellular energy dysregulation. As such, the recombinant protein study of AK3L1 is crucial in advancing our knowledge of cellular energy management and its broader implications in health and disease.